Public reprimand for Moderna - CASE/0316/10/24

Moderna has been publicly reprimanded by the Code of Practice Appeal Board for failure to provide a full and frank disclosure of all the facts in its response to a previous case (Case AUTH/3886/3/24).

In Case/0316/11/24, the Panel concluded that in failing to include all relevant information in its response to the previous complaint, Moderna had brought discredit upon, and reduced confidence in the pharmaceutical industry. The Panel reported the company to the Appeal Board, in accordance with Paragraph 10.2 of the Constitution and Procedure.

Self-regulation relies on full and frank disclosure of all the facts; the Appeal Board considered that a lack of transparency in this regard was completely unacceptable.

In addition to the public reprimand, the Appeal Board also decided to require a specific scope audit of Moderna’s procedures in relation to the ABPI Code. The audit will specifically focus on Moderna’s culture, governance and compliance framework.